TrialScientific reports2021
Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer.
Ryusuke Murakami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it